Weather , , 0°C

Psoriasis Drugs Market Estimated To Reach USD 39.00 Billion By 2027 | Key Players: Amgen, AbbVie, Novartis AG And Others

 Breaking News
  • No posts were found

Psoriasis Drugs Market Estimated To Reach USD 39.00 Billion By 2027 | Key Players: Amgen, AbbVie, Novartis AG And Others

March 28
20:14 2021
Psoriasis Drugs Market Estimated To Reach USD 39.00 Billion By 2027 | Key Players: Amgen, AbbVie, Novartis AG And Others

Reports And Data
Changing lifestyle, rising awareness about the condition, and advancements in genetic medicine have resulted in boosting the Psoriasis Drugs market. Psoriasis Drugs Market Size – USD 16.21 Billion in 2018, Market Growth – CAGR of 9.6%, Market Trends – The rising demand for Interleukin Inhibitors

The global psoriasis drugs market is forecast to reach USD 39.00 Billion by 2027, according to a new report by Reports and Data. Psoriasis can be defined as a skin condition, which accelerates the life cycle of skin cells. It results in cells to develop on the surface. It is usually considered to be a chronic condition. The condition has an unpredictable course of symptoms, significant comorbidities, and various external triggers impacting the condition that includes metabolic syndrome, arthritis, and cardiovascular diseases, among others. The immune system is considered to play an integral role in the condition. The condition also affects nails apart from skin. When a particular area on the skin is affected by the disease, the skin lesion is usually localized, which are sharply demarcated by plaques and red papules that are covered by silver or white scales. These lesions are generally symmetrical and cause stinging, itching, and pain. Herein the main aim of the treatment is to prevent the skin cells from growing quickly. There is no cure to the disease; however, these drugs help in managing the symptoms.

In context to region, Europe can be seen to occupy a prominent market share. The market share held by the region is attributed to continuously developing healthcare sector, rising focus on management of not just the condition but comorbidities as well, which are supporting the market growth in this region.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2384

Further key findings from the report suggest

  • The Psoriasis Drugs market held a market share of USD 16.21 Billion in the year 2018 that is forecasted to grow at a rate of 9.6% during the forecast period.
  • In context to Treatment Type, the Biologics segment generated the highest revenue of USD 6.32 Billion in the year 2018, with a growth rate of 9.9% during the forecast period. The ability of these drugs to treat the condition by targeting particular areas of the immune system thereby treating the condition form the base, results in its high acceptance among care providers that contributes to the revenue generated by this segment.
  • In context to Therapeutic Class, the Interleukin Inhibitors segment is projected to witness the fastest growth rate of 10.3% during the forecast period, which is expected to occupy 27.5% of the market by 2027. The growth rate witnessed by the segment is attributed to the significant role it plays in the pathogenesis of plaque psoriasis, one of the most common form of psoriasis, which results in its elevated demand among care providers.
  • In context to distribution channel, it is mentionable here that the E-commerce segment is projected to witness the fastest growth rate of 11.6% during the forecast period, which is expected to generate USD 7.80 Billion by 2027. The growth rate witnessed by the segment is resultant of continuous growth in the online medicine store and associated upsurge in online medicine shopping culture.
  • In context to Application, the Plaque Psoriasis segment held the largest market share of 53.0% in 2018, with a CAGR of 9.7% during the forecast period. The high occurrence rate of the condition and associated increased demand for drugs and medications for treating the disease contributes to the market share occupied by this segment.
  • In regards to the region, Asia Pacific is projected to witness the fastest growth rate of 10.3% during the forecast, which is expected to hold 4% of the market by 2027. The growth rate witnessed by the region is resultant of rising awareness about the importance of early diagnosis of the condition and unmet healthcare needs of care users that are opening new avenues for the market in this region.
  • Key participants include Amgen, Inc., AbbVie Inc., Novartis AG, Johnson & Johnson, AstraZeneca, Eli Lilly and Company, UCB, Celgene Corporation, Merck, and Sun Pharmaceutical Industries Ltd.

Buy Now: https://www.reportsanddata.com/checkout-form/2384

For the purpose of this report, Reports and Data have segmented the global Psoriasis Drugs market according to Treatment Type, Therapeutic Class, Distribution Channel, Application, and Region:

Treatment Type Outlook (Revenue, USD Billion; 2016-2027)

  • Topicals
  • Systemic
  • Biologics

Therapeutic Class Outlook (Revenue, USD Billion; 2016-2027)

  • Tumor Necrosis Factor Inhibitor
  • Interleukin Inhibitors
  • Anti-Inflammatory
  • Corticosteroids

Distribution Channel Outlook (Revenue, USD Billion; 2016-2027)

  • Hospitals and Clinics
  • E-commerce
  • Retail Pharmacies

Application Outlook (Revenue, USD Billion; 2016-2027)

  • Plaque Psoriasis
  • Guttate Psoriasis
  • Nail Psoriasis
  • Erythrodermic Psoriasis
  • Pustular Psoriasis
  • Intertriginous psoriasis
  • Others

Regional Outlook (Revenue, USD Billion; 2016-2027)

  • North America
  • Europe
  • Asia Pacific
  • MEA
  • Latin America

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/psoriasis-drugs-market

Table Of Content:

Chapter 1. Market Synopsis
    1.1. Market Definition
    1.2. Research Scope & Premise
    1.3. Methodology
    1.4. Market Estimation Technology
Chapter 2. Executive Summary
    2.1. Summary Snapshot, 2018-2027
Chapter 3. Indicative Metrics
Chapter 4. Psoriasis Drugs Market Segmentation & Impact Analysis
    4.1. Psoriasis Drugs Market Segmentation Analysis
    4.2. Industrial Outlook
         4.2.1. Market indicators analysis
         4.2.2. Market drivers analysis
                 4.2.2.1. Changing lifestyle
                 4.2.2.2. Advancements in genetic medicine

….

Chapter 10. Competitive Landscape
    10.1. Market Revenue Share By Manufacturers
    10.2. Manufacturing Cost Breakdown Analysis
    10.3. Mergers & Acquisitions
    10.4. Market positioning
    10.5. Strategy Benchmarking
    10.6. Vendor Landscape
Chapter 11. Company Profiles
    11.1. Amgen, Inc.
            11.1.1. Company Overview
            11.1.2. Financial Performance
            11.1.3. Technology Insights
            11.1.4. Strategic Initiatives
    11.2. AbbVie Inc.
            11.2.1. Company Overview
            11.2.2. Financial Performance
            11.2.3. Technology Insights
            11.2.4. Strategic Initiatives
    11.3. Novartis AG
            11.3.1. Company Overview
            11.3.2. Financial Performance
            11.3.3. Technology Insights
            11.3.4. Strategic Initiatives
    11.4. Johnson & Johnson
            11.4.1. Company Overview
            11.4.2. Financial Performance
            11.4.3. Technology Insights
            11.4.4. Strategic Initiatives
    11.5. AstraZeneca
           11.5.1. Company Overview
           11.5.2. Financial Performance
           11.5.3. Technology Insights
           11.5.4. Strategic Initiatives
    11.6. Eli Lilly and Company
           11.6.1. Company Overview
           11.6.2. Financial Performance
           11.6.3. Technology Insights
           11.6.4. Strategic Initiatives
    11.7. UCB
           11.7.1. Company Overview
           11.7.2. Financial Performance
           11.7.3. Technology Insights
           11.7.4. Strategic Initiatives

Continue…

About Us:

Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and development analysis, and demand estimation among others, we can help you invest your funds in the most beneficial areas for research and development.

Media Contact
Company Name: Reports and Data
Contact Person: John Watson
Email: Send Email
Phone: +1-212-710-1370
Address:40 Wall St. 28th floor
City: New York City
State: NY 10005
Country: United States
Website: https://www.reportsanddata.com/press-release/global-psoriasis-drugs-market

Related Articles